All Stories

  1. Will AI Make the Electronic Health Record More Efficient for Clinicians?
  2. Trends in Urinary Tract Infection Management in Women
  3. Comparative Analysis of Performance of Large Language Models in Urogynecology
  4. Healthcare disparities and pelvic organ prolapse operative complications: a nationwide analysis
  5. Ichthyosis uteri: A keratinizing squamous metaplasia of the endometrium with premalignant potential
  6. Rate of Mesh Erosion After Sacrocolpopexy With Concurrent Supracervical Compared With Total Hysterectomy
  7. Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu
  8. Health Care Disparities in Surgical Management of Pelvic Organ Prolapse: A Contemporary Nationwide Analysis
  9. COVID-19 and its effect on Instagram adoption by #OBGYN residency programs
  10. Applying Human-Centered Design Principles to Digital Syndromic Surveillance at a Mass Gathering in India: Viewpoint
  11. Neonatal and maternal outcomes among twin pregnancies stratified by mode of conception in the United States
  12. Perioperative outcomes of reconstructive surgery for apical prolapse in the very elderly: a national contemporary analysis
  13. Applying Human-Centered Design Principles to Digital Syndromic Surveillance at a Mass Gathering in India: Viewpoint (Preprint)
  14. A Comparison of Perioperative Outcomes, Readmission, and Reoperation for Sacrospinous Ligament Fixation, Uterosacral Ligament Suspension, and Minimally Invasive Sacrocolpopexy
  15. Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study
  16. Academic tweeting in #ObGyn. Where do we stand?
  17. Evacuation of a large traumatic vulvar haematoma with an intravaginal cosmetic approach
  18. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers
  19. A Novel Approach to Combined Vaginal and Laparoscopic Gynecological Surgery
  20. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
  21. Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer
  22. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
  23. In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers